Learn about RECIST 1.1 and how it can be applied to your clinical trial.

RECIST (Response Evaluation Criteria In Solid Tumors) is a set of published rules that define when cancer patients improve ("respond"), stay the same ("stable") or worsen ("progression") during treatments.

What’s New

Version 2.0.1

Improved RECIST calculations which includes percent changes from Nadir.
User can enter Baseline and up to 9 follow up time points.
Target lesion measurements can be designated as lymph nodes.

Ratings and Reviews

4.0 out of 5
1 Rating

1 Rating

App Privacy

The developer, PAREXEL International Corporation, has not provided details about its privacy practices and handling of data to Apple.

No Details Provided

The developer will be required to provide privacy details when they submit their next app update.


  • Family Sharing

    With Family Sharing set up, up to six family members can use this app.

You May Also Like